Changzhou Qianhong Biopharma Co., Ltd. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Changzhou Qianhong Biopharma Co., Ltd. with three other
companies in this sector in China:
Anhui Anke Biotechnology (Group) Company., Limited
sales of 1.10 billion Chinese Renmimbi [US$158.88 million]
of which 58%
was Biological Products),
Tianjin Lisheng Pharmaceutical Company Limited
(1.03 billion Chinese Renmimbi [US$149.20 million]
of which 100%
was Phamaceutical Manufacturing), and
Zhejiang Yatai Pharmaceutical Co.,Limited
(1.08 billion Chinese Renmimbi [US$156.95 million]
of which 57%
was CRO Service).
During the year ended December of 2017, sales at
Changzhou Qianhong Biopharma Co., Ltd. were 1.07 billion Chinese Renmimbi (US$154.42 million).
increase of 37.2%
versus 2016, when the company's sales were 776.38 million Chinese Renmimbi.
Sales of Bio-Pharmaceutical Industry saw an increase
37.3% in 2017, from
775.85 million Chinese Renmimbi to 1.07 billion Chinese Renmimbi.
Not all segments of Changzhou Qianhong Biopharma Co., Ltd. experienced an increase in sales in 2017:
sales of Other Operations fell 90.6% to 50,326.31 Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).